Ipsen to explore oral peptide innovations, advances and delivery
Speaking on Day 1 of the event, Joël will provide an opening address exploring the advances in non-invasive routes of administration of peptides with a focus on successful oral technologies progressing in the clinic. Key highlights of his presentation will include
• Peptides delivery landscape and importance of non-invasive routes of administration
• Oral peptides delivery - strong expectations and opportunities from the market
• Key oral peptides formulation excipients
• Oral peptides technologies progressed in the clinic
• Lessons learnt from clinical studies
• Future challenges & prospects
The presentation comes at a relevant time, with peptide therapeutics becoming more prevalent within the market due to their high potency and effectivity, self-emulsifying drug delivery systems and safety. With the rising demand for effective drugs and technology, it is an exciting time for peptide development and there is a need to understand and acknowledge the challenges for optimal commercialisation and prominence.
More details about Joël's presentation, as well as the full speaker line-up for the conference can be found on www.controlledreleasedelivery.com/
Now running for 15 years, Controlled Release Delivery 2018 aims to explore and to understand innovations in oral-lipid based and abuse deterrent formulations, nanoparticles and nanotechnologies, taste-masking and controlled release approaches, 3D printed dosage forms and functional film coats.
For those interested to attend, registration is now live on the event website and there is currently an Early Bird Discount of £200 which expires on 15 December 2017.
15th Controlled Release Delivery Conference
21-22 March 2018
Copthorne Tara Hotel, London, UK
--- END ---
For delegate registration enquiries, contact Kieran Ronaldson on kronaldson@smi-
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-